Among these genes, TP53, JUN, CAD, ACLY, IL-6, PPARG, THBS1, CXCL8, IMPDH2, and YARS were identified as key differential genes for Chidamide treatment of breast cancer based on high scores. Here, THBS1 is linked to breast carcinoma.